Navigation Links
Chicken Pox Hospitalizations Are Becoming Less

According to the available data, the introduction of chicken doctors because of chicken pox vaccine had reduced drastically the incidence of hospitalizations and visits to pox // . The latest issue of JAMA reports a research on the subject.

Varicella vaccine is recommended for routine immunization of children aged 12 to 18 months and for older susceptible children and adults in the United States, according to background information in the article. Before its licensure in 1995, almost everyone developed chickenpox; thus, incidence approximated the birth cohort, with about 13,000 hospitalizations and 100 to 150 deaths annually. Varicella vaccine coverage has increased steadily, reaching 81 percent in 2002 among children aged 19 to 35 months nationally, while varicella disease incidence has declined in all age groups. However, data documenting the impact of vaccination on varicella-related health care utilization have previously been limited.

Researchers from Centers for Disease Control and Prevention, Atlanta, had conducted a study to determine the patterns of hospitalization and ambulatory visits for chicken pox and their associated medical expenditures in the United States, evaluating these factors beginning in 1994 (before availability of varicella vaccine) through 2002 (7 years after vaccine licensure). Data included enrollees (children and adults) of more than 100 health insurance plans of approximately 40 large U.S. employers.

The researchers found that from the pre-vaccination period to 2002, hospitalizations due to chicken pox declined by 88 percent (from 2.3 to 0.3 per 100,000 population) and ambulatory visits declined by 59 percent (from 215 to 89 per 100,000 population). Hospitalizations and ambulatory visits declined in all age groups, with the greatest declines among infants younger than 1 year. Total estimated direct medical expenditures for chicken pox hospitalizations and ambulatory visits declined by 74 percent, from a
'"/>




Page: 1 2

Related medicine news :

1. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
2. Chickens Found To Have High Levels of Arsenic
3. The Effectiveness Of Chickenpox Vaccine Questioned
4. Vaccine To Stop the Spread of Chickenpox
5. Chicken-Pox vaccine not fool proof
6. Chicken pox beholds brain tumour risk
7. Super Bugs Contaminate UK Chickens
8. Chicken pox Spreads Across Firozabad
9. Chicken Eaters Have Decreased Risk Of Developing Colon Cancer
10. Punjabis Transfer Taste From Chicken To Prawns
11. U.S. Chicken Producers to Test Flocks for Bird Flu
Post Your Comments:
(Date:10/13/2008).... 13 /PRNewswire-USNewswire/ -- As the first-ever ...n Ki-Moon, on fistula is,scheduled to be presented...la announced a fourfold increase in the number of ...t, the campaign now works to prevent and treat,fis...Arab States. When it,was launched in 2003, it cove...
(Date:10/13/2008)...no AIDS Awareness Day Encourages Latinos to Get Te..., -- Latinos make up almost half of all newly dia...ty compared to 19 percent nationally., -- A week ...raging HIV,counseling and testing to coincide with...tober 15., -- October 14, Our Community, Our Resp...
(Date:10/13/2008)...has a greater effect on women, study found , ...e alcohol you drink, the more your brain shrinks, ...e is that, if you drink a lot, you,re going to hur...rofessor of neuroscience and experimental therapeu...llege of Medicine. "This is something we knew, but...
(Date:10/13/2008)...Calif., Oct. 13 /PRNewswire/ -- Integrated Medical...rator developing fully,integrated products for cri...10(k) clearance from the U.S. Food and Drug Admini...ase" intensive care unit (ICU)., "FDA clearance o...,company as we continue to demonstrate the economi...
Breaking Medicine News(10 mins):Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 3Health News:Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos 2Health News:Excess Drinking Shrinks the Brain 2Health News:Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit 2Health News:Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit 3
...hes identify two causes that can cause hearing los...uses, greying hereditary syndrome and type 1 diabe...on of Otolaryngology—Head and Neck Surgery. In the... previously unreported hereditary syndrome compose...
...wth is encouraged at some other part of the body, ...g the damaged bone. Researchers for the study, w...he Proceedings of the National Academy of Sciences... the usual practice of tissue processing to develo...
...y the FDA issued a public health advisory, warning...other infection among women who have taken Danco L...pristone -- which when taken with misoprostol can ...d deaths were reported among women who took the dr...
...g red color of strawberries may be the culprit for...ating the popular summer fruit, Swedish researcher...ed to the red color, but it is not clear exactly h...more proteins," Rikard Alm of Lund University said...
Other Medicine News:Health News:Studies On Hearing Loss Discovers New Causes 2Health News:Its Possible To Grow Bone To Replace The Damaged Bone 2
(Date:10/13/2008)...ion of Genomic DNA from Multiple Cancer Population...tudies, ANN ARBOR, Mich., Oct. 13 /-...nt with SAIC-Frederick to amplify DNA samples for ...s was selected to amplify and standardize total ge... cancer patients. The Rubicon,GenomePlex(TM) Whole...
(Date:10/12/2008)... siRNAs Examined Alone and in Combination with Che...- Quark Pharmaceuticals, Inc., a,development-stage... novel,RNA interference (RNAi)-based therapeutics,...published results on efficacy of siRNA targeting,i...lung cancer (NSCLC) in,the edition dated October 1...
(Date:10/12/2008)...K, Mass. and WASHINGTON, Oct. 12 /PRNewswire-First... ) today announced results from an analysis,of nea...egistries, which,are designed to confirm the perfo...ting Coronary Stent System in real-world practice....AXUS Stent reduced clinical,restenosis in patients...
(Date:10/10/2008)...Z CREEK, Mich., Oct. 10 /- Diplomat S...cience has selected Diplomat,Specialty Pharmacy to...rge,scale, national Therapy Optimization Study for...wo year TOP MS study, is to examine the benefits o...on compliance, adherence and,patient outcomes. Tar...
Breaking Medicine Technology:Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 2Rubicon Provides Genome Amplification for the Cancer Genome Atlas Project 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 2Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 3Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Rice scientists make breakthrough in single molecule sensing 2138 1Rice scientists make breakthrough in single molecule sensing 2138 2Genesee 26 Wyoming Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11155 1Genesee 26 Wyoming Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11155 2Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 1330 1Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 1330 2Mayo Clinic Proceedings Contributors Discuss Impact of Donor Organ Allocation System 1330 3Charles River Laboratories International Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11147 1Charles River Laboratories International Board Member Should Use Sarbanes Oxley Disclosure Rules in Non Profit Role Asserts 1199 SEIU 11147 2
...mp; CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 17, 200...l company focused on,the discovery and development...ced encouraging preclinical data of AV-412, a nove...of EGFR/HER2 using,AVEO,s unique EGFR mutant and d...s from the preclinical study showed that AV-412,is...
...ation on April 17, 2007 at AACR, SAN DIEGO, April ...s, Inc. presented data from an in vitro study show...natural killer (NK),cell-mediated anti-tumor respo...umor cells and enhanced antibody-dependent cellula...n at the Annual,Meeting of the American Associatio...
Other Medicine Technology:AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 2AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 3AVEO Presents Preclinical Efficacy Data on AV-412, a Novel Oral,Tyrosine Kinase Inhibitor of EGFR/HER2 for EGFR Mutant and,Drug-Resistant Lung Cancer 4Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor,Activity of Natural Killer Cells 2Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor,Activity of Natural Killer Cells 3Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor,Activity of Natural Killer Cells 4
The Vision Central Monitoring System combines Invivo's AutoNet™ wireless networking with a combination of central monitoring and clinical information system (CIS) features. With auto-admission a
The Panorama Central Station includes bi-directional communication with Datascope bedside monitors, optional 72 hours of disclosure and a touch screen user interface.
... MedSystem III DLE (Drug List Editor) Multi-Channe...nfusion technology. The instrument combines three ...tures and clinical versatility in an unparalleled ...n, the MedSystem III Infusion System simplifies th...
... of the first steps any hospital or health system ...tive tools available for physicians and nurses. Es...an documentation and electronic medical record (EM...eve this goal. In fact, its the most reliable clin...
Medicine Products: